We are pleased to see the federal Lipitor lawsuits progressing, and look forward to the litigation’s first bellwether trials. The outcome of these trials may provide valuable insight into how juries will rule in similar Lipitor diabetes claims.
New York, New York (PRWEB) February 03, 2015
Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) filed on behalf of patients who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin medication continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to court documents dated January 30th, the Court has designated four cases as bellwether trial candidates: Daniels v. Pfizer, Case No. 2:14-1400; Hempstead v. Pfizer, Case. No. 2:14-1879; Radon v. Pfizer, Case No. 2:14-1502; and Durocher v. Pfizer, Case No. 7:13-1965. Daniels v. Pfizer will be the first to go to trial in October 2015. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)
“We are pleased to see the federal Lipitor lawsuits progressing, and look forward to the litigation’s first bellwether trials. The outcome of these trials may provide valuable insight into how juries will rule in similar Lipitor diabetes claims,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing a number of Lipitor lawsuit plaintiffs, and continues to offer free and confidential case reviews to individuals who allegedly developed Types 2 diabetes due to the medication.
Lipitor Diabetes Litigation
Lipitor is a statin medication used to lower cholesterol in conjunction with diet and exercises. In February 2012, the U.S. Food & Drug Administration (FDA) announced that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The label change was prompted by the publication of a study in JAMA: Internal Medicine the previous month which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. *
Since then, court documents indicate that more than 2,000 Lipitor diabetes claims have been filed in the multidistrict litigation underway in South Carolina, all of which allege that use of the statin increases the risk that a patient will develop Type 2 diabetes. Pfizer, Inc., the manufacturer of Lipitor, is also accused of concealing its alleged association with diabetes in order to protect sales of the medication. Plaintiffs further assert that the label modifications made by Pfizer following the FDA’s 2012 mandate still do not sufficiently inform patients about the potential association between Lipitor and diabetes.
Individuals who developed new-onset Type 2 diabetes allegedly due to Lipitor may be entitled to pursue their own claim against Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com